Front Range Biosciences, a technology provider for the breeding and production of new plant varieties and seeds in hemp, coffee and regulated cannabis industries, on Monday announced it completed an $8.5 million capital raise it has dubbed an insider round.
The Insider Round allows FRB to expand its lead over new entrants in the space, propelled by data-driven innovation and a strong team.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
"With this round of funding, we will increase the expansion of our Clean Stock program, breeding program and intellectual property portfolio allowing FRB to continue to scale our operations and bring new products to market" said Dr. Jon Vaught, CEO and Co-Founder of Front Range Biosciences.
"The continued global advancement of cannabis legalization has created an opportunity for unprecedented growth and innovation in agriculture. We look forward to furthering our growth trajectory as we continue our mission of providing the highest quality products to our community of growers and farmers."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!